Negative Trials

TRILOGY ACSNo significant difference in ischemic outcomes despite greater P2Y12 receptor inhibition with prasugrel than with clopidogrel

ISIS-2, GUSTO: Exclusion Criteria

Today’s Trial Design Challenges

NIH Health Care Systems Research Collaboratory

Cluster Randomization

Framingham Heart Study Funding Cut by 40 Percent

Novel Anticoagulant Trials

Patient-Centered Outcomes Research

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)